Bayforest Capital LTD 10x Genomics, Inc. Transaction History
Bayforest Capital LTD
- $229 Billion
- Q2 2025
A detailed history of Bayforest Capital LTD transactions in 10x Genomics, Inc. stock. As of the latest transaction made, Bayforest Capital LTD holds 94,864 shares of TXG stock, worth $1.17 Million. This represents 0.48% of its overall portfolio holdings.
Number of Shares
94,864
Previous 25,558
271.17%
Holding current value
$1.17 Million
Previous $223 Million
392.34%
% of portfolio
0.48%
Previous 0.1%
Shares
3 transactions
Others Institutions Holding TXG
# of Institutions
335Shares Held
116MCall Options Held
442KPut Options Held
149K-
Cathie Wood Ark Investment Management LLC | St. Petersburg, Fl13.9MShares$172 Million1.33% of portfolio
-
Vanguard Group Inc Valley Forge, PA12.4MShares$154 Million0.0% of portfolio
-
Black Rock Inc. New York, NY6.39MShares$79.1 Million0.0% of portfolio
-
Sumitomo Mitsui Trust Holdings, Inc.6.02MShares$74.5 Million0.04% of portfolio
-
Nikko Asset Management Americas, Inc.6.01MShares$74.4 Million0.74% of portfolio
About 10x Genomics, Inc.
- Ticker TXG
- Exchange NASDAQ
- Sector Healthcare
- Industry Health Information Services
- Shares Outstandng 95,046,400
- Market Cap $1.18B
- Description
- 10x Genomics, Inc., a life science technology company, develops and sells instruments, consumables, and software for analyzing biological systems in North America, Europe, the Middle East, Africa, China, and the Asia Pacific. The company provides chromium and chromium connect instruments, microfluidic chips, slides, reagents, and other consumabl...